Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples